Dr Ling Yang
|Tel||+44 (0)1865 743936|
- Clinical Trial Service Unit
Ling Yang qualified in Medicine at South-Eastern University, China, in 1995, then gained her MSc in Bio-statistics in 1998 at the same university, and her PhD in Epidemiology at the University of Tampere in Finland in 2005. Before moving to the University of Oxford in 2007, she worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institute in Stockholm (Sweden). She is a Senior Epidemiologist at CTSU, University of Oxford, and also leads the Long-term Follow-up Working Group for the China Kadoorie Biobank study. Her main research focuses on women’s reproductive health, environmental causes of chronic diseases, especially cancer, based on big cohort studies, and evidence-based medicine using national survey data to provide strategies for chronic disease prevention and control in developing countries.
Breastfeeding and the risk of maternal cardiovascular disease: a prospective study of 300,000 Chinese women
Peters SAE. et al, (2017), Journal of The American Heart Association
Family History and Stroke Risk in China: Evidence from a Large Cohort Study.
Tian T. et al, (2017), J Stroke, 19, 188 - 195
Association between diabetes and cause-specific mortality in rural and urban China
Bragg F. et al, (2017), JAMA
Parenthood and the risk of diabetes in men and women: a 7- year prospective study of 0.5 million individuals
Peters SAE. et al, (2016), Diabetologia
Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China.
Yang L. et al, (2015), Eur Heart J, 36, 1178 - 1185